To solve this problem, a combined treatment of TRAIL with drugs that sensitize glioma cells to apoptosis induced by TRAIL or other agents (chemotherapeutics, radiotherapy, lipoxygenase, carbenoxolone) has been used [23]. The gene discussed is TNFSF10; the disease is glioma.